ABBOTT LABORATORIES — Cash Flow Charts
12 quarters of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-7.2% -$102M
$1.31B
Free Cash Flow↓-1.8% -$17M
$916M
Investing Cash Flow↓-4224.3% -$19.85B
$-20.32B
Financing Cash Flow↑+942.5% +$19.37B
$17.31B
Capex↓-17.6% -$85M
$399M
Acquisitions
—
Stock Buybacks↓-35.7% -$100M
$180M
Dividends Paid↑+7.0% +$72M
$1.10B
Stock-Based Comp↑+9.7% +$28M
$317M
Debt Issued↑+1985900.0% +$19.86B
$19.86B
Debt Repaid↑+41.5% +$415M
$1.42B
D&A↑+13.4% +$45M
$381M
SBC Allocated Expense↑+9.7% +$28M
$317M
SBC Unrecognized Cost↑+15.7% +$124M
$914M